Diabetes

Sensulin - Sensulin is a diabetes drug discovery company developing a once-a-day glucose-responsive insulin.

MelliCell - MelliCell develops therapeutics for diabetes and obesity using proprietary technologies that model weight gain in human fat cells in vitro.

AnTolRx - Our lead program addresses significant unmet needs in the field of Type 1 Diabetes

AmideBio - AmideBio develops and commercializes peptide research reagents and clinical products for clinical and therapeutic marketplaces.

Hedia - Hedia is a personal diabetes-assistant, based on artificial intelligence.

Surf Bio - Surf Bio develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy.

Takeda Cambridge - Takeda Cambridge specializes in developing oral diabetes medications.

Abarceo Pharma AB - Abarceo Pharma has identified a novel diabetes target located on beta cells and a novel mechanism of action enabling a therapeutic.

Access Pharmaceuticals - Access Pharmaceuticals develops treatments for oncology and diabetes.

HYGIEIA - Hygieia is a developer of a diabetes insulin guidance system used to enhance and simplify insulin therapy.

© 2025 bioDAO.ai